Sirolimus 0.4% ( DrugBank: Sirolimus )

1 disease

ID	Disease name (Link within this page)	Number of trials
158	Tuberous sclerosis	1

158. Tuberous sclerosis

Clinical trials : 112 / Drugs : 71 - (DrugBank : 19) / Drug target genes : 35 - Drug target pathways : 118

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03363763 (ClinicalTrials.gov)	April 12, 2017	1/12/2017	Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex	Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate ...	Angiofibroma of Face;Tuberous Sclerosis	Drug: Sirolimus 0.2%;Drug: Sirolimus 0.4%;Drug: Placebo ointment	Aucta Pharmaceuticals, Inc	NULL	Recruiting	2 Years	21 Years	All	45	Phase 2	United States;China

First Previous1Next Last